Noul

노을 · 376930

Health Care Medical Devices · KOSDAQ

Small-cap

Market cap US$35.9M (₩49.5B)

Overview

Noul makes miLab™, a compact, toaster-sized device that automates blood and cancer diagnostic tests, including malaria screening, peripheral blood analysis, and cervical cell analysis, without requiring specialist laboratory staff.

It supplies this system to diagnostic laboratories worldwide, with a particular focus on small and mid-sized labs that lack the infrastructure or trained personnel for conventional microscopy-based testing. Listed on KOSDAQ, Korea's tech-focused small-cap board, Noul's platform runs its AI analysis entirely on the device itself, requiring no internet connection or cloud server.

Summary is AI-generated and may contain errors · figures from DART filings

Financials

Source: DART · FY ending Dec · latest FY2025
Revenue · FY2025
US$3.7M
▲ +219.8% YoY
Operating profit · FY2025
−US$14.6M
Loss narrowed
Net income · FY2025
−US$14.5M
Loss narrowed

Revenue

  • FY2023US$2M
  • FY2024US$1.2M
  • FY2025US$3.7M

Operating profit

  • FY2023−US$11.7M
  • FY2024−US$16.5M
  • FY2025−US$14.6M

Net income

  • FY2023−US$11.8M
  • FY2024−US$16.3M
  • FY2025−US$14.5M

Key ratios (FY2025)

ROE
-77.7%
Debt/Eq
52.7%
Op. margin
-392.0%
Net margin
-389.6%
Rev. YoY
▲ +219.8%

Price charts coming soon

Interactive price history isn't here yet. Would you use it?

For informational purposes only. This is not investment advice, a recommendation, or a solicitation to buy or sell any security. Do your own research; any investment decision is your own responsibility.

Data from DART, Korea's official corporate-filing system. Data sourced from official DART filings. Accuracy is not guaranteed. Figures are as of the date shown. As of 2026-06-12 (KST). · FX: 1 USD ≈ ₩1,380 (2026-06-01).

Company summaries are generated and may contain errors; financial figures are mapped directly from official filings.